Benzinga | Aug 12, 2021 06:34AM EDT

Evaxion Biotech Q2 EPS $(0.36) Down From $(0.24) YoY

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.36) per share. This is a 50 percent decrease over losses of $(0.24) per share from the same period last year.